About Lenz-Majewski hyperostotic dysplasia
Lenz-Majewski hyperostotic dysplasia is a rare disease catalogued by Orphanet (ORPHA:2658). It is associated with the PTDSS1 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Lenz-Majewski hyperostotic dysplasia trials.
Search ClinicalTrials.gov for "Lenz-Majewski hyperostotic dysplasia" or filter by Orphanet code ORPHA:2658 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Lenz-Majewski hyperostotic dysplasia trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Lenz-Majewski hyperostotic dysplasia. Updated daily.